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Translocation breakpoints of several types of leukemia have been sequenced in order to identify factors that lead to DNA breakage (for example, topoisomerase 2 in MLL and PML-RARA leukemia). 1, 2 Several studies in chronic myeloid leukemia (CML) have shown a possible association of breakpoints with ALU interspersed repeat elements (IREs), [3] [4] [5] [6] but remained inconclusive due to their small sample size. We sequenced 308 BCR-ABL1 fusion genes and performed a bioinformatic analysis with greater statistical power to identify breakpoint motifs.
The research was approved by the ethics committees of the participating institutions. All CML patients in this study expressed BCR-ABL1 mRNA with breakpoints in the major breakpoint cluster region of BCR. The BCR-ABL1 genomic breakpoint was identified using one of three methods: long range, 7 short range 8 or inverse PCR. 9 These methods rely on the fact that BCR breakpoints are tightly clustered, so that using a limited number of BCR primers it should be possible to amplify across the BCR-ABL1 junction. The success rates of the three methods were around 90%, 99% and 65%, respectively. The use of several methods with a high overall success rate avoids skewing of the data due to the limitations of a specific technique (for example, restriction enzyme sites). The data of 32 patients and five common CML cell lines were previously published. 7, 10 In BCR there were 129 breakpoints between exon 13 and the end of exon 14 (giving rise to e13a2 mRNA), and 179 breakpoints between exon 14 and the end of exon 15 (e14a2 mRNA) (Figure 1a ). Ten breakpoints were in BCR exons: in these cases, the partial exon was spliced out of the mRNA. In ABL1 256 breakpoints were located in the large intron between the first alternative exon 1b and the second alternative exon 1a. Thirtyeight breakpoints were located in the smaller intron between exon 1a and exon 2 ( Figure 1b) . Two breakpoints were in the short intron between exon 2 and exon 3, resulting in the expression of e13a3 BCR-ABL1 mRNA. Twelve breakpoints were in a region of B10 kb upstream of ABL1 extending from the last exon of the EXOSC2 gene. No breakpoints were found in ABL1 exons. A modified Anderson-Darling test showed non-uniformity of distribution of BCR breakpoints (Po10
), but not ABL1 breakpoints (P40.05).
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MEME software was used to search for sequence motifs that might be over-represented in the vicinity of breakpoints (10 bp up-and downstream of BCR breaks, and 100 bp around ABL1 breaks). 12 Where sequence neighborhoods overlapped for multiple breakpoints, the contiguous intervals were combined resulting in 34 distinct sequences in BCR, and 195 sequences in ABL1. The de novo search in ABL1 returned only motifs resulting from the presence of IREs, while no motifs were over-represented in BCR, despite the significantly non-uniform distribution of breakpoints in BCR. The ABL1 gene is rich in ALU and other IREs, which together make up B50% of the entire ABL1 breakpoint region, and it has been proposed that these elements are somehow involved in the genesis of the BCR-ABL1 fusion. ALU and L1 are the two most frequent types of IRE in the ABL1 breakpoint region, accounting for more than half of all repeats. In the relevant portion of BCR there is a single ALU repeat contiguous with an L1 repeat, and two small L2 repeats. We calculated the interval between each ABL1 breakpoint and the nearest ALU or L1 repeat and obtained a quantile-quantile (QQ) plot by comparing this distribution of intervals with a reference distribution (all 203 384 intervals between every nucleotide in the 203 kb reference sequence and its nearest repeat). This was also done for 1000 sets of 308 uniformly selected 'breaks' in place of the actual breakpoints to determine an approximate envelope of QQ plots under uniformity. The distribution of intervals for the CML patients lay within this envelope (Supplementary Figures), indicating that BCR-ABL1 breakpoints are no more frequent than would be expected in and around these IREs.
The de novo search for motifs resulted in the discovery in ABL1 of a large palindrome with 243 bp of perfect reverse complementarity separated by B2 kb (Figure 1b ). It is difficult to assign statistical significance to this observation, but within the whole 141 Mb of chromosome 9 there are only eight such palindromes with arm lengths of X200 bp and loop lengths of o2 kb. In BCR, the nearest palindrome was downstream of exon 16, with an arm length of 100 bp and a loop length of B3.6 kb. In chromosome 22, there are 23 palindromes of comparable size and separation. Palindromic sequences can result in non-B DNA conformation and have been associated with pathogenic recombination in humans. 13 It is possible that secondary structures in DNA are involved in initiating an interaction between chromosomes 9 and 22, as postulated for a 76 kb duplicon in 9q34 and 22q11.2. 14 We searched for 50 sequence motifs previously reported in association with DNA breakpoints (Supplementary Data). For every breakpoint, we determined the shortest distance between the breakpoint and each of the 50 motifs, upstream and downstream and on both genomic strands. These were compared (via QQ plots) with similar distances for cyclic permutations of the motifs, so as to reduce the effects of polynucleotide composition. None of the motifs was significantly associated with BCR-ABL1 breakpoints.
Analysis of the breakpoint sequences showed an increase in the frequency of microhomology, a hallmark of non-homologous endAccepted article preview online 16 April 2013; advance online publication, 7 May 2013 Letters to the Editor joining (NHEJ), which is a major pathway of DNA repair in translocations. NHEJ can utilize several bases of homology between the broken ends of chromosomes in a manner similar to single-strand annealing. As DNA contains four bases, homology of X2 bp would be expected in B16.2% of random fusions (allowing for the effect of sequence composition). Microhomology, defined as X2 bp of homology at the translocation junction, was observed in 32% of sequences (Po10 À 12 ), irrespective of whether junctions involved an IRE (34% versus 27% if neither break in IRE, P40.05). In six patients, both BCR and ABL1 breakpoints were in an ALU: 3/6 showed microhomology, and two of these were of 410 bp. Small insertions of 'filler' DNA at the breakpoint were seen in 19 patients, and are also a feature of NHEJ. Larger insertions were found in five breakpoints: three of these insertions were derived from IREs.
This series of CML patient breakpoints is by far the largest ever reported. In 4300 patients, there were no two individuals with identical BCR-ABL1 fusion sequences, highlighting the applicability of this approach as a patient-specific marker of the leukemic clone. 15 There is a non-uniform distribution of breakpoints in BCR that cannot be explained by association with any recognized sequence motif. In contrast to some previous reports, the distribution of breakpoints in ABL1 showed no significant clustering and we found no significant association of breakpoints with IREs after controlling for their frequent occurrence in the relevant region of chromosome 9. This substantially larger study reduced the risk of false discovery, and increased the power to identify any relevant sequence motif. Our only finding of possible relevance was a large palindrome in ABL1, which might possibly predispose to DNA breakage or interchromosomal recombination. This analysis of BCR-ABL1 breakpoints in the major breakpoint cluster region cannot explain why these particular regions of the BCR and ABL1 genes are more often translocated in CML than in others. Our analysis, which was restricted to the sequences immediately adjacent to the breakpoint junction, may fail to identify relevant motifs that interact only when brought together in secondary DNA structures or that are separated from the breakpoint by migration of the Holliday junction. Alternatively, secondary events following the initial translocation might obscure the original site of breakage, as evidenced by the presence of insertions, inversions, or deletions involving the chimeric sequence. Further progress in understanding the mechanisms underlying the BCR-ABL1 translocation is likely to require a different analytical approach or cellular modeling of the translocation. 
